[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2011/4182,2011,A1Locationinpatent:Page/Pagecolumn34
[2]Sulur,Manjunatha;Sharma,Parhalad;Ramakrishnan,Ravi;Naidu,Ravi;Merifield,Eric;Gill,DuncanM.;Clarke,AdrianM.;Thomson,Colin;Butters,Michael;Bachu,Sreekanth;Benison,ColinH.;Dokka,Nagaraju;Fong,EmilyR.;Hose,DavidR.J.;Howell,GarethP.;Mobberley,SiobhanE.;Morton,SimonC.;Mullen,AlexanderK.;Rapai,Jayan;Tejas,Bharathi[OrganicProcessResearchandDevelopment,2012,vol.16,#11,p.1746-1753]
[3]CurrentPatentAssignee:ASTRAZENECAPLC;PHILIPKEEGEN-WO2006/75139,2006,A2Locationinpatent:Page/Pagecolumn8
[4]Locationinpatent:schemeortableLuker,Tim;Bonnert,Roger;Brough,Steve;Cook,AnthonyR.;Dickinson,MarkR.;Dougall,Iain;Logan,Chris;Mohammeda,RukhsanaT.;Paine,Stuart;Sanganee,HiteshJ.;Sargent,Carol;Schmidt,JerzyA.;Teague,Simon;Thom,Stephen[BioorganicandMedicinalChemistryLetters,2011,vol.21,#21,p.6288-6292]
[5]CurrentPatentAssignee:ASTRAZENECAPLC-WO2004/106302,2004,A1Locationinpatent:Page26-27
[1]CurrentPatentAssignee:ASTRAZENECAPLC;PHILIPKEEGEN-WO2006/75139,2006,A2Locationinpatent:Page/Pagecolumn12-13
[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2011/4182,2011,A1Locationinpatent:Page/Pagecolumn37
[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2011/4182,2011,A1Locationinpatent:Page/Pagecolumn41-42
[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2011/4182,2011,A1
[2]Sulur,Manjunatha;Sharma,Parhalad;Ramakrishnan,Ravi;Naidu,Ravi;Merifield,Eric;Gill,DuncanM.;Clarke,AdrianM.;Thomson,Colin;Butters,Michael;Bachu,Sreekanth;Benison,ColinH.;Dokka,Nagaraju;Fong,EmilyR.;Hose,DavidR.J.;Howell,GarethP.;Mobberley,SiobhanE.;Morton,SimonC.;Mullen,AlexanderK.;Rapai,Jayan;Tejas,Bharathi[OrganicProcessResearchandDevelopment,2012,vol.16,#11,p.1746-1753]
Title: Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy.
Journal: Molecular pharmacology 20160501
Title: Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework.
Journal: Nature reviews. Drug discovery 20140601
Title: Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981.
Journal: Bioorganic & medicinal chemistry letters 20111101
Title: Royer JF, et al. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils. Eur J Clin Invest. 2008 Sep;38(9):663-71.
Title: Luker T, et al. Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981. Bioorg Med Chem Lett. 2011 Nov 1;21(21):6288-92.
Title: Snell N, et al. Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD. Respir Med. 2013 Nov;107(11):1722-30.
